# Miragen Therapeutics, Inc. (MGEN)

Source: https://www.quantisnow.com/company/MGEN
Generated: 2026-11-19T00:01:44.349Z

- Ticker: MGEN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2014

## Latest MGEN news and filings

- 2021-03-15 20:38 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Miragen Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-miragen-therapeutics-inc-512415)
- 2021-03-10 12:17 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-493140)
- 2021-02-19 13:02 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-413581)
- 2021-02-16 21:30 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-402548)
- 2021-02-16 20:09 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-400950)
- 2021-02-08 22:41 UTC [SEC Form 4] [SEC Form 4 filed by L Joseph Turner](https://www.quantisnow.com/insight/sec-form-4-filed-by-l-joseph-turner-365239)
- 2021-02-08 22:40 UTC [SEC Form 4] [SEC Form 4 filed by Evan Peter Harwin](https://www.quantisnow.com/insight/sec-form-4-filed-by-evan-peter-harwin-365236)
- 2021-02-08 22:40 UTC [SEC Form 4] [SEC Form 4 filed by S. Jeffrey Hatfield](https://www.quantisnow.com/insight/sec-form-4-filed-by-s-jeffrey-hatfield-365234)
- 2021-02-08 22:40 UTC [SEC Form 4] [SEC Form 4 filed by Tomas Kiselak](https://www.quantisnow.com/insight/sec-form-4-filed-by-tomas-kiselak-365232)
- 2021-02-08 22:38 UTC [SEC Form 4] [SEC Form 4 filed by Arlene Morris](https://www.quantisnow.com/insight/sec-form-4-filed-by-arlene-morris-365224)
- 2021-01-22 00:45 UTC [SEC Form 3] [SEC Form 3 filed by Barrett Katz](https://www.quantisnow.com/insight/sec-form-3-filed-by-barrett-katz-304358)
- 2021-01-22 00:33 UTC [SEC Form 4] [SEC Form 4 filed by Barrett Katz](https://www.quantisnow.com/insight/sec-form-4-filed-by-barrett-katz-304348)
- 2021-01-20 20:55 UTC [SEC Form 4] [SEC Form 4 filed by A. Jason Leverone](https://www.quantisnow.com/insight/sec-form-4-filed-by-a-jason-leverone-298773)
- 2021-01-20 20:48 UTC [SEC Form 4] [SEC Form 4 filed by Jonathan Violin](https://www.quantisnow.com/insight/sec-form-4-filed-by-jonathan-violin-298762)
- 2021-01-20 13:01 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-297290)
- 2021-01-20 01:11 UTC [SEC Form 4] [SEC Form 4 filed by Diana Escolar](https://www.quantisnow.com/insight/sec-form-4-filed-by-diana-escolar-296304)
- 2021-01-20 01:04 UTC [SEC Form 4] [SEC Form 4 filed by M. Lee Rauch](https://www.quantisnow.com/insight/sec-form-4-filed-by-m-lee-rauch-296297)
- 2021-01-19 21:18 UTC [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-295409)
- 2021-01-19 12:00 UTC [Leadership Update] [miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team](https://www.quantisnow.com/insight/miragen-therapeutics-announces-company-name-change-to-viridian-therapeutics-and-292404)
- 2021-01-16 00:47 UTC [SEC Form 4 filed by Stuart William Marshall](https://www.quantisnow.com/insight/sec-form-4-filed-by-stuart-william-marshall-289835)
- 2021-01-11 21:08 UTC [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-273962)
- 2021-01-11 17:07 UTC [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-273311)
- 2021-01-07 12:36 UTC [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-264835)
- 2021-01-05 11:04 UTC [SEC Form SC 13D filed](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-253415)
- 2021-01-04 21:16 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-251302)
- 2020-12-23 22:05 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-237813)
- 2020-12-23 05:15 UTC [SEC Form E filed](https://www.quantisnow.com/insight/sec-form-e-filed-235567)
- 2020-12-17 12:00 UTC [miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease](https://www.quantisnow.com/insight/miragen-enters-into-license-agreement-with-xencor-for-use-of-222523)
- 2020-11-23 13:30 UTC [Vividion Brings in Proven Industry Leader Jeffrey Hatfield as Chief Executive Officer](https://www.quantisnow.com/insight/vividion-brings-in-proven-industry-leader-jeffrey-hatfield-as-chief-174975)
- 2020-11-10 21:15 UTC [miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates](https://www.quantisnow.com/insight/miragen-reports-third-quarter-2020-financial-results-and-provides-corporate-150161)
- 2020-10-28 11:00 UTC [miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.](https://www.quantisnow.com/insight/miragen-therapeutics-inc-announces-acquisition-of-viridian-therapeutics-inc-123280)
- 2020-10-05 20:05 UTC [miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)](https://www.quantisnow.com/insight/miragen-announces-internal-review-of-preliminary-topline-data-for-the-82946)
- 2020-09-14 21:02 UTC [miRagen Announces Leadership Transition and Review of Strategic Alternatives ](https://www.quantisnow.com/insight/miragen-announces-leadership-transition-and-review-of-strategic-alternatives-47402)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MGEN
- Earnings history: https://www.quantisnow.com/earnings/MGEN
- Dividend history: https://www.quantisnow.com/dividends/MGEN
- Insider transactions: https://www.quantisnow.com/insiders/MGEN
- Options chain: https://www.quantisnow.com/options/MGEN
- SEC 8-K filings only: https://www.quantisnow.com/company/MGEN/8-k
- RSS and alerts for MGEN: https://www.quantisnow.com/docs/rss-feeds.md
